OpenVSafe by OpenVAERS
Search V-safe

UPL-28634-98520

2 vaccinations 2 coded responses 11 check-ins 2 free-text entries 1 call case
Sex
Male
Age at first dose
05-11
ZIP prefix
913 / CA
Registered
2021-12-12
Relationship
Child or adolescent in my care
Guardian
7WS-29585-23909
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-19
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-10
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-12
    Registered in v-safe
  4. 2021-12-12
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  5. 2021-12-13
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-14
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-12-16
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-12-18
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-12-24
    Health check-in — day 14, dose 2, dependent
    Feeling: Fair
    Adult check-in
  10. 2022-01-01
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  11. 2022-01-16
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2022-03-11
    Survey response — 3 months, dose 2, dependent
    MedDRA: Cough, Headache, Oropharyngeal pain — Feeling: Good · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: coughing, headache, sore throat
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-03-11
    Report sent to call center — 3 months, dose 2, dependent
    Be unable to do their normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  14. 2022-03-14
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  15. 2022-06-11
  16. 2022-12-12
    Survey response — 12 months, dose 2, dependent
    MedDRA: Cough — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: coughing
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-19Pfizer-BioNTech No
22021-12-10Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-03-11 Successful
2022-03-14
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 11 — 3 months, dose 2, dependent

2022-03-11

Symptoms: coughing, headache, sore throat

Release 12 — 12 months, dose 2, dependent

2022-12-12

Symptoms: coughing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDHeadache · · ✓
SDOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release